(Q67900560)
Statements
Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML Study 8498 (English)
Y. Ravindranath
E. Abella
J. P. Krischer
J. Wiley
S. Inoue
M. Harris
A. Chauvenet
C. S. Alvarado
R. Dubowy
1 November 1992